Hipolin Intrinsic Value

HIPOLIN • Consumer Goods
Current Stock Price
₹56.76
Primary Intrinsic Value
₹17.03
Market Cap
₹17.0 Cr
-70.0% Downside
Median Value
₹17.03
Value Range
₹17 - ₹67
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

HIPOLIN Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹17.03 ₹13.62 - ₹20.44 -70.0% EPS: ₹0.04, Sector P/E: 25x
Book Value Method asset ₹66.67 ₹60.00 - ₹73.34 +17.5% Book Value/Share: ₹26.67, P/B: 2.5x
Revenue Multiple Method revenue ₹60.00 ₹54.00 - ₹66.00 +5.7% Revenue/Share: ₹40.00, P/S: 1.5x
PEG Ratio Method growth ₹17.03 ₹15.33 - ₹18.73 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹17.03 ₹15.33 - ₹18.73 -70.0% Revenue Growth: 6.0%, Adj P/E: 18.5x
Graham Defensive Method conservative ₹17.03 ₹15.33 - ₹18.73 -70.0% EPS: ₹0.04, BVPS: ₹26.67
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check HIPOLIN share price latest .

Valuation Comparison Chart

HIPOLIN Intrinsic Value Analysis

What is the intrinsic value of HIPOLIN?

Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Hipolin (HIPOLIN) is ₹17.03 (median value). With the current market price of ₹56.76, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹17.03 to ₹66.67, indicating ₹17.03 - ₹66.67.

Is HIPOLIN undervalued or overvalued?

Based on our multi-method analysis, Hipolin (HIPOLIN) appears to be trading above calculated value by approximately 70.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 5.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.62 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Asset Turnover Ratio 0.92x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-3 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2024 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2023 ₹-5 Cr ₹-5 Cr Negative Cash Flow 3/10
March 2022 ₹3 Cr ₹2 Cr Positive Free Cash Flow 7/10